Skip to content

Author

Yan-Ming Cheng

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Tofacitinib and esophageal-related manifestations in systemic sclerosis: a retrospective real-world cohort focused on lower esophageal sphincter pressure changes

Esophageal dysfunction represents one of the most prevalent, treatment-refractory visceral complications of systemic sclerosis (SSc). Janus kinase (JAK) inhibitors exhibit anti-inflammatory and antifibrotic effects against skin and interstitial lung lesions in SSc, yet evidence linking JAK inhibition to esophagea...

Ying Liu, Yan-Ming Cheng, W. Gao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.